设为首页| 加入收藏
网站首页 本刊简介 编委会 投稿指南 过刊浏览 联系我们 下载专区
最新消息:
位置:首页 >> 期刊文章
舒肝宁治疗化疗药物所致肝损伤的临床疗效观察
作者:魏阳 姚文秀 周行 王理杨 谢华 赵新 
单位:四川省肿瘤医院 内科 成都 610041 
关键词:舒肝宁注射液 化疗 肝损伤 
分类号:
出版年,卷(期):页码:2010,2(2):9-11
摘要:

目的 观察舒肝宁注射液治疗肿瘤患者化疗药物所致轻度肝损伤的临床疗效。方法 将化疗后有轻度肝损伤的46例恶性肿瘤患者随机分为治疗组和对照组。治疗组26例,患者化疗后静脉输注舒肝宁注射液,每日1次,连续治疗10天。对照组20例,未静脉输注舒肝宁注射液,采用常规口服保肝药治疗。观察两组治疗前后丙氨酸氨基转移酶(ALT)及总胆红素(TBil)的变化及疗效差别。结果 治疗后治疗组的ALT显著低于治疗前,其疗效和肝脏功能改善均优于对照组,差异有统计学意义(P < 0.05)。结论 舒肝宁注射液治疗化疗药物所致轻度肝损伤疗效明显,具有较强的保肝护肝作用。

Objective To observe  the protective effectiveness of Shuganning  injection on hepatic  injury caused by chemotherapy drug. Methods Total of 46 patients with  tumors who had  slight hepatic  injury after chemotherapy were  randomly divided  into  treatment group and control group.  In  treatment group, Shuganning was additionally added by intravenous infusion to 26 patients. However, the other 20 patients in control group were given routine liver-protective drugs only. The change of ALT was researched before and after therapy to test the effectiveness of Shuganning injection. Results The serum level of ALT in treatment group was obviously lower than that of control group, the difference was signiicant (P < 0.05). Conclusions Shuganning injection has noticeable effect to relieve hepatic injury caused by chemotherapy.

基金项目:
作者简介:
参考文献:
服务与反馈:
文章下载】【加入收藏
 

地址:北京市朝阳区京顺东街8号
邮政编码:100015  电话:010-84322058  传真:010-84322059 Email:editordt@163.com